StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Addex Therapeutics's total debt was CHF 0 at Dec 31, 2025. For fiscal 2025 it was CHF 0. The highest annual figure on record is CHF 0 in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 0–
FY2024Dec 31, 2024CHF 0–
FY2023Dec 31, 2023CHF 0–
FY2022Dec 31, 2022CHF 0–
FY2021Dec 31, 2021CHF 0–
FY2020Dec 31, 2020CHF 0–
FY2019Dec 31, 2019CHF 0–
FY2018Dec 31, 2018CHF 0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CHF 0–
Q4 FY2024Dec 31, 2024CHF 0–
Q4 FY2023Dec 31, 2023CHF 0–
Q4 FY2022Dec 31, 2022CHF 0–
Q4 FY2021Dec 31, 2021CHF 0–
Q4 FY2020Dec 31, 2020CHF 0–
Q4 FY2019Dec 31, 2019CHF 0–
Q4 FY2018Dec 31, 2018CHF 0–

More Addex Therapeutics figures

See a number that looks wrong?